Rockwell Medical, Inc. (NASDAQ:RMTI) Sees Significant Decline in Short Interest

Rockwell Medical, Inc. (NASDAQ:RMTI – Get Free Report) was the recipient of a large drop in short interest during the month of October. As of October 30th, there was short interest totaling 35,533 shares, a drop of 49.3% from the October 15th total of 70,068 shares. Based on an average daily volume of 24,708 shares, the days-to-cover ratio is presently 1.4 days. Approximately 0.9% of the company’s shares are sold short.

Rockwell Medical Trading Down 2.1%

Rockwell Medical stock traded down $0.14 during mid-day trading on Monday, hitting $6.88. The company’s stock had a trading volume of 18,307 shares, compared to its average volume of 40,835. The business has a 50 day moving average price of $7.80 and a 200-day moving average price of $8.07. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.47 and a quick ratio of 2.27. Rockwell Medical has a 12 month low of $4.89 and a 12 month high of $12.90. The stock has a market cap of $27.75 million, a price-to-earnings ratio of -4.81 and a beta of 1.75.

Rockwell Medical (NASDAQ:RMTI – Get Free Report) last posted its earnings results on Thursday, November 12th. The company reported ($0.59) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.41). Rockwell Medical had a negative return on equity of 16.04% and a negative net margin of 7.79%. The firm had revenue of $19.12 million for the quarter, compared to analysts’ expectations of $18.22 million. As a group, analysts forecast that Rockwell Medical will post -0.90 EPS for the current year.

Institutional Investors Weigh In On Rockwell Medical

A hedge fund recently raised its stake in Rockwell Medical stock. Renaissance Technologies LLC increased its holdings in shares of Rockwell Medical, Inc. (NASDAQ:RMTI – Free Report) by 36.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 639,120 shares of the company’s stock after purchasing an additional 170,800 shares during the quarter. Renaissance Technologies LLC owned 1.62% of Rockwell Medical worth $571,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 23.31% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on RMTI. HC Wainwright reaffirmed a “buy” rating and set a $20.00 target price on shares of Rockwell Medical in a research report on Friday, September 11th. Zacks Research upgraded Rockwell Medical from a “strong sell” rating to a “hold” rating in a report on Thursday. Wall Street Zen raised Rockwell Medical to a “hold” rating in a research report on Saturday, July 25th. Finally, Weiss Ratings upgraded shares of Rockwell Medical from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, October 8th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $20.00.

Read Our Latest Stock Analysis on Rockwell Medical

Rockwell Medical Company Profile

(Get Free Report)

Rockwell Medical, Inc. is a healthcare company that develops, manufactures and distributes products used in the treatment of people with kidney disease, particularly patients receiving hemodialysis. Its offerings include acid and bicarbonate concentrates used to prepare dialysis solutions, as well as related supplies and services for dialysis providers. The company has also developed pharmaceutical products for use in dialysis care. Founded in 1996, Rockwell Medical is based in the United States and serves dialysis providers in the U.S. and select international markets.

Further Reading

Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.